Medrx USA, Inc.
🇺🇸United States
Etodolac-lidocaine Patch in Subjects Experiencing Acute Delayed Onset Muscle Soreness
Phase 3
Completed
- Conditions
- Acute Delayed Onset Muscle Soreness (DOMS)
- Interventions
- Drug: PlaceboDrug: Etodolac-lidocaine topical patch
- First Posted Date
- 2016-03-01
- Last Posted Date
- 2016-09-12
- Lead Sponsor
- MEDRx USA, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT02695381
- Locations
- 🇺🇸
Lotus Clinical Research, Pasadena, California, United States
Etodolac-Lidocaine Patch in the Treatment of Acute Low Back Pain
Phase 3
Completed
- Conditions
- Low Back Pain
- Interventions
- Drug: PlaceboDrug: Etoreat®(Etodolac-Lidocaine Topical Patch)
- First Posted Date
- 2013-10-23
- Last Posted Date
- 2018-01-17
- Lead Sponsor
- MEDRx USA, Inc.
- Target Recruit Count
- 232
- Registration Number
- NCT01968005
Safety & Efficacy Study of MRX-7EAT Patch in the Treatment of Pain of the Shoulder
Phase 3
Completed
- Conditions
- TendonitisBursitisShoulder Pain
- Interventions
- Drug: MRX-7EAT
- First Posted Date
- 2012-01-09
- Last Posted Date
- 2018-01-16
- Lead Sponsor
- MEDRx USA, Inc.
- Target Recruit Count
- 210
- Registration Number
- NCT01506154
MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Ankle Sprains
Phase 3
Completed
- Conditions
- Ankle Sprains
- Interventions
- First Posted Date
- 2010-09-10
- Last Posted Date
- 2018-01-17
- Lead Sponsor
- MEDRx USA, Inc.
- Target Recruit Count
- 600
- Registration Number
- NCT01198834
MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Tendonitis and Bursitis of the Shoulder
Phase 3
Completed
- Conditions
- Acute TendonitisBursitis
- Interventions
- Drug: PlaceboDrug: MRX-7EAT
- First Posted Date
- 2010-07-13
- Last Posted Date
- 2018-01-17
- Lead Sponsor
- MEDRx USA, Inc.
- Target Recruit Count
- 350
- Registration Number
- NCT01161615